Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Total revenue from sales of goods and services

Latest
$123.67M
↑ 334% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
$28.47M
Historical baseline
PeriodValueYoY Change
TTM$123.67M+63.5%
2024$75.62M-
2023$0.00-
2022$0.00-
2021$0.00-
2020$0.00-
2019$0.00-